A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia

Study Identifier
214868-007
CT.gov Identifier
EudraCT Identifier
EUCTIS ID
Not available
For general inquiries, please contact

Study Details

Medical Condition
  • Neuroscience - Other
  • Study Drug
  • AGN-214868
  • AGN-214868 Placebo (Vehicle)
  • Phase
    Phase 2
    Sex
    Female & Male
    Age
    18 - 80 Years

    Protocol Summary

    This is a safety and efficacy study of AGN-214868 in patients with postherpetic neuralgia (PHN).

    Study Locations

    Location
    Status
    Location
    Agave Clinical Research, LLC
    Mesa, Arizona, United States, 85202
    Status
    Not applicable
    Location
    Territory Neurology & Research Institute
    Tucson, Arizona, United States, 85704
    Status
    Not applicable
    Location
    Neuro-Pain Medical Center
    Fresno, California, United States, 93710
    Status
    Not applicable
    Location
    University of California, Irvine
    Irvine, California, United States, 92697
    Status
    Not applicable
    Location
    Loma Linda University
    Loma Linda, California, United States, 92354
    Status
    Not applicable
    Location
    Northern California Research Corp
    Sacramento, California, United States, 95821
    Status
    Not applicable
    Showing {first} - {last} of {total} Results